BioLineRx (BLRX) Interest Coverage Ratio (2013 - 2025)
BioLineRx (BLRX) posted Interest Coverage Ratio of 12.09 for Q4 2025, up 66.57% on a QoQ basis from 7.26 in Q3 2025, and up 1124.04% year-over-year from 0.99 in Q4 2024.
BioLineRx (BLRX) has 13 years of Interest Coverage Ratio data on file, last reported at 12.09 in Q4 2025.
- In Q4 2025, Interest Coverage Ratio rose 1124.04% year-over-year to 12.09; the TTM figure through Dec 2025 stood at 8.04 (up 259.11% YoY), while the FY2025 annual figure was 8.04, up 259.11% from the prior year.
- Interest Coverage Ratio improved to 12.09 in Q4 2025, from 7.26 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 32.68 in Q1 2022 and bottomed at 19.92 in Q4 2023.
- A 5-year average of 12.09 and a median of 8.95 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio slumped 636.56% — and 2025, when it jumped 1124.04%.
- Year by year, Interest Coverage Ratio stood at 32.34 in 2021, then tumbled by 88.52% to 3.71 in 2022, then slumped by 636.56% to 19.92 in 2023, then jumped by 104.96% to 0.99 in 2024, then jumped by 1124.04% to 12.09 in 2025.
- The last three Interest Coverage Ratio figures came in at 12.09 (Q4 2025), 7.26 (Q3 2025), and 8.34 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.88 |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 | 12.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.09 |
| Sep 30, 2025 | 7.26 |
| Jun 30, 2025 | 8.34 |
| Mar 31, 2025 | 5.69 |
| Dec 31, 2024 | 0.99 |
| Sep 30, 2024 | 3.32 |
| Jun 30, 2024 | 2.77 |
| Mar 31, 2024 | 5.19 |
| Dec 31, 2023 | 4.28 |
| Sep 30, 2023 | 14.76 |
| Jun 30, 2023 | 7.42 |
| Mar 31, 2023 | -14.06 |
| Dec 31, 2022 | 6.33 |
| Sep 30, 2022 | 26.51 |
| Jun 30, 2022 | 20.06 |
| Mar 31, 2022 | 32.68 |
| Dec 31, 2021 | 32.34 |
| Sep 30, 2021 | 23.82 |
| Jun 30, 2021 | 26.91 |
| Mar 31, 2021 | 18.22 |
| Dec 31, 2020 | 11.36 |
| Sep 30, 2020 | 15.39 |
| Jun 30, 2020 | 14.06 |
| Mar 31, 2020 | 16.52 |
| Dec 31, 2019 | 11.87 |
| Sep 30, 2019 | 11.13 |
| Jun 30, 2019 | 14.72 |
| Mar 31, 2019 | 12.48 |
| Dec 31, 2018 | 21.52 |
| Sep 30, 2018 | 564.73 |
| Jun 30, 2018 | 520.64 |
| Mar 31, 2018 | 32.18 |
| Dec 31, 2017 | 1,281.33 |
| Sep 30, 2017 | 1,176.17 |
| Jun 30, 2017 | 1,731.33 |
| Mar 31, 2017 | 883.50 |
| Dec 31, 2016 | 438.40 |
| Sep 30, 2016 | 1,122.00 |
| Jun 30, 2016 | 773.20 |
| Mar 31, 2016 | 944.00 |
| Dec 31, 2015 | -820.00 |
| Sep 30, 2015 | 39.59 |
| Jun 30, 2015 | 2,083.00 |
| Mar 31, 2015 | 254.53 |
| Dec 31, 2014 | 83.82 |
| Sep 30, 2014 | 13.44 |
| Jun 30, 2014 | 8.99 |
| Mar 31, 2014 | 50.32 |
| Dec 31, 2013 | 7.99 |
| Sep 30, 2013 | 5.92 |
| Jun 30, 2013 | 9.79 |
| Mar 31, 2013 | 11.70 |